| Overcoming preexisting humoral immunity to AAV using capsid decoys F Mingozzi, XM Anguela, G Pavani, Y Chen, RJ Davidson, DJ Hui, ... Science translational medicine 5 (194), 194ra92-194ra92, 2013 | 343 | 2013 |
| Characterization of OSR1, a member of the mammalian Ste20p/germinal center kinase subfamily W Chen, M Yazicioglu, MH Cobb Journal of Biological Chemistry 279 (12), 11129-11136, 2004 | 94 | 2004 |
| Genetic evidence for convergence of c-Kit–and α4 integrin–mediated signals on class IA PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells BL Tan, MN Yazicioglu, D Ingram, J McCarthy, J Borneo, DA Williams, ... Blood 101 (12), 4725-4732, 2003 | 94 | 2003 |
| Mutations in ERK2 binding sites affect nuclear entry MN Yazicioglu, DL Goad, A Ranganathan, AW Whitehurst, EJ Goldsmith, ... Journal of biological chemistry 282 (39), 28759-28767, 2007 | 64 | 2007 |
| Mxi2 promotes stimulus‐independent ERK nuclear translocation B Casar, V Sanz‐Moreno, MN Yazicioglu, J Rodríguez, MT Berciano, ... The EMBO journal 26 (3), 635-646, 2007 | 62 | 2007 |
| Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissues K High, M Yazicioglu, X Anguela US Patent 9,840,719, 2017 | 58 | 2017 |
| The nuclear localization of ERK2 occurs by mechanisms both independent of and dependent on energy A Ranganathan, MN Yazicioglu, MH Cobb Journal of Biological Chemistry 281 (23), 15645-15652, 2006 | 58 | 2006 |
| Composition and methods for highly efficient gene transfer using AAV capsid variants MN Yazicioglu, F Mingozzi, X Anguela, KA High US Patent 9,909,142, 2018 | 48 | 2018 |
| Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes DJ Hui, E Basner-Tschakarjan, Y Chen, RJ Davidson, G Buchlis, ... Molecular Therapy 21 (9), 1727-1737, 2013 | 47 | 2013 |
| The transcriptional ETS2 repressor factor associates with active and inactive Erks through distinct FXF motifs S Polychronopoulos, M Verykokakis, MN Yazicioglu, ... Journal of biological chemistry 281 (35), 25601-25611, 2006 | 34 | 2006 |
| PRRG4-associated compositions and methods of use thereof in methods of tumor diagnosis KA High, FR Khazi, K Chu, L Monaldini, MN Yazicioglu, S Murphy US Patent 8,071,293, 2011 | 27 | 2011 |
| Experimental variables that affect human hepatocyte AAV transduction in liver chimeric mice C Zou, KOA Vercauteren, E Michailidis, M Kabbani, I Zoluthkin, C Quirk, ... Molecular Therapy Methods & Clinical Development 18, 189-198, 2020 | 23 | 2020 |
| Cellular localization and characterization of cytosolic binding partners for Gla domain-containing proteins PRRG4 and PRRG2 MN Yazicioglu, L Monaldini, K Chu, FR Khazi, SL Murphy, H Huang, ... Journal of Biological Chemistry 288 (36), 25908-25914, 2013 | 17 | 2013 |
| Engineered aav capsids with increased tropism and aav vectors comprising the engineered capsids and methods of making and using same X Anguela, S Armour, N Keiser, S Somanathan, MN Yazicioglu US Patent App. 17/050,362, 2021 | 1 | 2021 |
| Methods of regulating adeno-associated virus production M Yazicioglu, AY Ozdemir US Patent App. 18/535,857, 2024 | | 2024 |
| Secretable protein induced immune tolerization and treatment of autoimmune, allergic and other diseases and disorders DW Anderson, BL Gurda, F Mingozzi, MN Yazicioglu, W Quinn US Patent App. 17/777,954, 2023 | | 2023 |
| Vetor de vírus adeno-associado (aav) que compreende uma proteína de capsídeo vp1, composições farmacêuticas compreendendo o mesmo, e seus usos MN Yazicioglu, F Mingozzi, X Anguela, KA High | | 2023 |
| Composition and methods for highly efficient gene transfer using AAV capsid variants MN Yazicioglu, F Mingozzi, X Anguela, KA High US Patent 11,279,950, 2022 | | 2022 |
| Aav-variant og sammensætninger, fremgangsmåder og anvendelser til genoverførsel til celler, organer og væv KA High, MN Yazicioglu, X Anguela | | 2020 |
| Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues KA High, MN Yazicioglu, X Anguela | | 2020 |
